Skip to main content

ML P18 4 mg (Doxazosin Mesylate 4 mg)

Pill with imprint ML P18 4 mg is Orange, Elliptical/Oval and has been identified as Doxazosin Mesylate 4 mg. It is supplied by DAVA Pharmaceuticals, Inc.

Doxazosin is used in the treatment of high blood pressure; benign prostatic hyperplasia; raynaud's syndrome and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P18 4 mg

Doxazosin mesylate 4 mg ML P18 4 mg
Doxazosin mesylate 4 mg ML P18 4 mg Front
Doxazosin mesylate 4 mg ML P18 4 mg Back
Doxazosin mesylate 4 mg ML P18 4 mg

Doxazosin Mesylate

ML P18 4 mg
4 mg
13.00 mm
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
DAVA Pharmaceuticals, Inc.
National Drug Code (NDC)
67253-0382 (Discontinued)
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type B potato, magnesium stearate, sodium lauryl sulfate, FD&C Yellow No. 6, aluminum oxide, lactose

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.